Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Overview
Biotechnology
General Medicine
Authors
Affiliations
Infectious diseases are a significant burden on public health and economic stability of societies all over the world. They have for centuries been among the leading causes of death and disability and presented growing challenges to health security and human progress. The threat posed by infectious diseases is further deepened by the continued emergence of new, unrecognized, and old infectious disease epidemics of global impact. Over the past three and half decades at least 30 new infectious agents affecting humans have emerged, most of which are zoonotic and their origins have been shown to correlate significantly with socioeconomic, environmental, and ecological factors. As these factors continue to increase, putting people in increased contact with the disease causing pathogens, there is concern that infectious diseases may continue to present a formidable challenge. Constant awareness and pursuance of effective strategies for controlling infectious diseases and disease emergence thus remain crucial. This review presents current updates on emerging and neglected infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with particular focus on WHO top priority emerging infectious diseases (EIDs) and neglected tropical infectious diseases.
Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.
Kumar A, Saini S, Anvikar A, Mishra N, Misra G Mol Biotechnol. 2025; .
PMID: 40042766 DOI: 10.1007/s12033-025-01385-w.
Andrade L, de Souza C, da Paz W, de Gois Souza D, Goes J, Camargo E Ther Adv Infect Dis. 2025; 12:20499361251313830.
PMID: 39896218 PMC: 11783498. DOI: 10.1177/20499361251313830.
Evaluation and analysis of respiratory infectious disease prevention behaviors in older adults.
Yu L, Liu M, Tan Q, Wang D, Chen X, Zhao M Front Public Health. 2024; 12:1448984.
PMID: 39722707 PMC: 11668675. DOI: 10.3389/fpubh.2024.1448984.
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.
Zimna M, Krol E NPJ Vaccines. 2024; 9(1):212.
PMID: 39505865 PMC: 11541885. DOI: 10.1038/s41541-024-01005-9.
Fernandes Melo Reis R, Pontes Silva A, Veiga Torres A, de Cassia Alves Iemini R, Lapa I, Franco L Future Med Chem. 2024; 16(20):2169-2188.
PMID: 39474787 PMC: 11559368. DOI: 10.1080/17568919.2024.2419376.